Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GULDSMED BOYE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   2.6% 2.4% 1.2% 0.8% 1.1% 1.5% 4.7% 4.3%   Credit score (0-100)   63 64 81 90 85 74 46 48   Credit rating   BBB BBB A AA A A BBB BBB   Credit limit (kDKK)   0.0 0.0 231.2 1,050.7 532.1 40.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,177 6,963 8,474 9,202 7,558 7,190 0.0 0.0   EBITDA   266 935 2,740 2,978 1,583 1,161 0.0 0.0   EBIT   75.7 661 2,433 2,679 1,158 751 0.0 0.0   Pre-tax profit (PTP)   4.3 421.2 2,223.8 2,549.7 998.6 484.7 0.0 0.0   Net earnings   1.5 326.3 1,732.7 1,986.3 776.1 376.2 0.0 0.0   Pre-tax profit without non-rec. items   4.3 421 2,224 2,550 999 485 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   283 566 514 383 880 668 0.0 0.0   Shareholders equity total   5,604 5,930 7,663 9,539 10,205 10,466 10,124 10,124   Interest-bearing liabilities   500 2,355 0.0 0.0 555 0.0 0.0 0.0   Balance sheet total (assets)   12,410 18,256 21,249 18,486 18,717 18,700 10,124 10,124   Net Debt   231 2,196 -1,523 -499 237 -603 -9,745 -9,745     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,177 6,963 8,474 9,202 7,558 7,190 0.0 0.0   Gross profit growth   -1.5% 34.5% 21.7% 8.6% -17.9% -4.9% -100.0% 0.0%   Employees   17 20 17 18 17 17 0 0   Employee growth %   -5.6% 17.6% -15.0% 5.9% -5.6% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,410 18,256 21,249 18,486 18,717 18,700 10,124 10,124   Balance sheet change%   -1.1% 47.1% 16.4% -13.0% 1.2% -0.1% -45.9% 0.0%   Added value   265.7 934.6 2,739.9 2,978.1 1,457.2 1,161.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -189 860 -477 -565 -63 -757 -668 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.5% 9.5% 28.7% 29.1% 15.3% 10.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.6% 4.5% 12.4% 13.6% 6.3% 4.0% 0.0% 0.0%   ROI %   1.2% 9.4% 29.4% 29.9% 11.3% 7.1% 0.0% 0.0%   ROE %   0.0% 5.7% 25.5% 23.1% 7.9% 3.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   45.3% 32.6% 36.5% 52.1% 55.0% 56.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   86.9% 234.9% -55.6% -16.8% 15.0% -51.9% 0.0% 0.0%   Gearing %   8.9% 39.7% 0.0% 0.0% 5.4% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   29.0% 19.1% 19.3% 0.0% 62.9% 96.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0   Current Ratio   1.7 1.6 1.5 2.0 2.2 2.2 0.0 0.0   Cash and cash equivalent   268.6 159.8 1,523.5 499.1 317.6 602.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   5,006.7 5,882.5 6,596.4 8,703.8 9,465.9 9,582.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   16 47 161 165 86 68 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   16 47 161 165 93 68 0 0   EBIT / employee   4 33 143 149 68 44 0 0   Net earnings / employee   0 16 102 110 46 22 0 0